Bank of America Just Raised Its Dividend 14%. The Buyback Is the Bigger Story.
2026-07-25 01:31
•Eric Volkman •The Motley Fool
•••••• •••••••••••••••• Axe Capital view
Bank of America’s Buyback Outshines Dividend Raise
A 14% dividend hike grabs attention, but BAC's $40bn buyback program is key for returns.
Bank of America raised its dividend by 14%, a solid move signaling strong earnings and confidence. But the real story is the ongoing $40 billion share buyback program. The bank has already repurchased $13.2 billion in the first half of 2026, with around $17 billion left to deploy. Buybacks reduce the number of shares outstanding, effectively increasing earnings per share and boosting returns for shareholders. While BAC is a US bank, the rand often tracks dollar strength, so any movement in USD/ZAR can impact local banks like Standard Bank or FirstRand by influencing offshore funding costs and foreign investor appetite. For now, though, South African banks don’t show the same aggressive capital return programs, making BAC’s approach stand out globally. If dollar strength falters or US rates drop unexpectedly, Bac’s appeal might weaken, especially with rand volatility. Still, BAC’s buyback emphasizes shareholder value in a way SA banks have yet to match. this is just my opinion and not financial advice
Watch USD/ZAR closely and consider trimming exposure to rand-hedged risks. For South African banks, I’d stay selective, favouring names with robust capital buffers like Standard Bank but waiting on aggressive buyback plays.
- Bank of America (BAC)
- USD/ZAR
- Standard Bank
- US Federal Reserve alters rate policy unexpectedly
- Rand volatility increases sharply due to local or global shocks
6/10
Bank of America raised its quarterly dividend by 14% to $0.32 per share, reflecting strong earnings and passing Federal Reserve stress tests. However, the more significant story is the company's robust $40 billion share buyback program, of which $13.2 billion was spent in the first half of 2026 alone, with approximately $17 billion remaining. Combined with positive fundamentals and economic conditions, the stock is positioned as a strong buy candidate.
This article was originally published by The Motley Fool and has been adapted here for Axe Capital Trading News.
Publisher: The Motley Fool
Author: Eric Volkman
Categories: Macro, Central Banks, Equities, Earnings, Capital Returns, Financials
Tickers: BAC, BACPB, BACPE, BACPK, BACPL, BACPM, BACPN, BACPO, BACPP, BACPQ, BACPS, BMLPG, BMLPH, BMLPJ, BMLPL, MERPK
Sentiment: Positive - The company demonstrated strong financial health by passing Fed stress tests with flying colors, reporting robust year-over-year increases in revenue and profitability, and maintaining healthy deposits and loans. The 14% dividend increase and substantial $40 billion buyback authorization signal management confidence in long-term growth and shareholder value creation. The stock has outpaced the S&P 500 benchmark, and the author rates it as a 'very strong buy candidate.'
Keywords: dividend raise, share buyback, earnings, Federal Reserve stress tests, shareholder returns, financial stocks
Insights:
- BAC: Positive: The company demonstrated strong financial health by passing Fed stress tests with flying colors, reporting robust year-over-year increases in revenue and profitability, and maintaining healthy deposits and loans. The 14% dividend increase and substantial $40 billion buyback authorization signal management confidence in long-term growth and shareholder value creation. The stock has outpaced the S&P 500 benchmark, and the author rates it as a 'very strong buy candidate.'
- BACPB: Positive: The company demonstrated strong financial health by passing Fed stress tests with flying colors, reporting robust year-over-year increases in revenue and profitability, and maintaining healthy deposits and loans. The 14% dividend increase and substantial $40 billion buyback authorization signal management confidence in long-term growth and shareholder value creation. The stock has outpaced the S&P 500 benchmark, and the author rates it as a 'very strong buy candidate.'
- BACPE: Positive: The company demonstrated strong financial health by passing Fed stress tests with flying colors, reporting robust year-over-year increases in revenue and profitability, and maintaining healthy deposits and loans. The 14% dividend increase and substantial $40 billion buyback authorization signal management confidence in long-term growth and shareholder value creation. The stock has outpaced the S&P 500 benchmark, and the author rates it as a 'very strong buy candidate.'